\
&
Contact us
This was 9 months ago
LocationBrussels and online
ProgrammesThe EU-funded projects European Citizen Science (ECS) and IMPETUS and the European Research Executive Agency (REA) are the organisers of this cluster event.
The event will focus on the impact of public engagement on evidence-based policy-making and will bring together researchers and policy makers to discuss this topic. Furthermore the event:
All information, including registration forms for online participation and EoI for onsite participation, are available in the announcement on the REA website.
Programme
The event takes place in Brussels. Three parts of the programme will also be webstreamed.
About citizen science and public engagement
Citizen science and public engagement in scientific research activities contribute to a vibrant society. Horizon Europe promotes co-creation and co-design through the engagement of citizens and civil society. This has the potential to improve the excellence and impact of research, and to deepen the relationship - and trust - between science and our societies.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.